-
J.P. Morgan Adding St Jude Medical to JPM Focus List
Thursday, July 21, 2011 - 8:08am | 171J.P. Morgan Chase & Co. is out with a research report on St. Jude Medical (NYSE: STJ), and it has an Overweight rating and a $57 price target on shares. It is also adding shares to the JPM Focus List. In a note to clients, J.P. Morgan Chase & Co. writes, "We're reiterating our Overweight...
-
Benzinga's Top Upgrades
Thursday, July 21, 2011 - 8:00am | 130Analysts at Robert W. Baird upgraded Robert Half International Inc (NYSE: RHI) from “neutral” to “outperform.” RHI's shares closed at $25.82 yesterday. RHI's trailing-twelve-month revenue is $3.32 billion. Analysts at Wunderlich upgraded Riverbed Technology Inc (NASDAQ: RVBD) from “hold” to “buy...
-
News Summary for July 20, 2011
Thursday, July 21, 2011 - 7:53am | 701This is your Benzinga news summary and traders' outlook for Thursday, July 21, 2011, covering headlines from overnight and Thursday's pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading slightly lower as traders wait for several blue-chip companies to report...
-
J.P. Morgan Underweight On Edwards Lifesciences
Thursday, July 21, 2011 - 7:40am | 105J.P. Morgan Chase & Co. is out with a research report on Edwards Lifesciences (NYSE: EW), and it has an Underweight rating and a $78 price target on shares. In a note to clients, J.P. Morgan Chase & Co. writes, "Wednesday after the close, the FDA's Circulatory System Devices panel voted in...
-
Morgan Keegan Reports on EW Sapien Approval
Thursday, July 21, 2011 - 7:40am | 81Morgan Keegan has issued a report that Edwards Lifesciences Corporation's (NYSE: EW) Sapien was approved by the Circulatory Devices Advisory Panel. According to ther report, "The panel seemed relatively satisfied that the benefit of the Sapien valve was significant enough in the studied population...
-
Morgan Keegan Reports STJ 2Q11 Results
Thursday, July 21, 2011 - 7:33am | 84Morgan Keegan has issued a report following the second quarter results posted by St. Jude Medical (NYSE: STJ). According to the results, "Even with lower CRM sales than expected, St Jude Medical reported second quarter results of $1.45 billion in revenues and earnings of $0.85, both in-line with...
-
MELA Sciences Responds to Congressional Testimony on Medical Device Regulation at the FDA
Thursday, July 21, 2011 - 7:19am | 294MELA Sciences Inc. (NASDAQ: MELA) issued the following statements after yesterday's hearing on "Regulatory Reform Series #5 - FDA Medical Device Regulation: Impact on American Patients, Innovation and Jobs" by the U.S. House Committee on Energy and Commerce's Subcommittee on Oversight and...
-
Piper Jaffray Reiterates Overweight and PT of $57 on St. Jude Medical
Thursday, July 21, 2011 - 7:16am | 63Piper Jaffray reiterated its Overweight rating on St. Jude Medical (NYSE: STJ). At the same time, the rating agency left its price target on the company's stock unchanged at $57. On Wednesday, STJ added 2.11% to its value to finish the day at $47.81. However, its shares lost some of yesterday's...
-
Piper Jaffray Provides Color on Edwards Lifesciences
Thursday, July 21, 2011 - 7:10am | 146Piper Jaffray provided color on Edwards Lifesciences (NYSE: EW). In a research report published today, the rating agency commented on FDA's favorable response to the company's new product. In the report, Piper Jaffray states, “The FDA held an advisory panel meeting for EW's Sapien® valve on...
-
JP Morgan Adds St Jude Medical To Focus List
Thursday, July 21, 2011 - 6:56am | 107JP Morgan has added St Jude Medical (NYSE: STJ) to the JP Morgan Focus List, stating "Yesterday's 2Q results and the lowering of 2H guidance was in our view a clearing event for the stock. The US ICD market has yet to stabilize, but this is now well reflected in management guidance and for the...
-
ValuEngine Issues Buy on China Medical Technologies
Thursday, July 21, 2011 - 6:51am | 31ValuEngine issued a Buy recommendation on China Medical Technologies (NASDAQ: CMED). On Wednesday, CMED lost 3.02% of its value to finish the day at $6.43.
-
Jefferies PT Changes For 7/21, Part 2
Thursday, July 21, 2011 - 6:41am | 191Jefferies & Company has changed the price target on the following companies: Hansen Natural Corp. (NASDAQ: HANS) Buy, PT from $85.00 to $90.00 Mattel, Inc. (NASDAQ: MAT) Buy, PT from $31.00 to $33.00 Nalco Holding (NYSE: NLC) Hold, PT from $30.00 to $38.80 Northern Trust (NASDAQ: NTRS) Hold...
-
Stocks to Watch for Thursday 7/21/2011: Fresh 52 Week Highs and Lows
Thursday, July 21, 2011 - 5:36am | 2699Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Wednesdays's trading session (listed from highest total volume to lowest): 1) Nalco Holding (NYSE: NLC): Shares...
-
Stocks Took a Breather 07-20-2011
Wednesday, July 20, 2011 - 7:37pm | 992Cusick's Corner Stocks took a breather, a little profit taking after yesterday's rally. Financials led the day on news from E-Trade (ETFC) and US Bancorp (USB). The Financial Select Sector ETF (XLF) was up +1.14% to close at 15 and the option volume was almost 80% higher than the average daily...
-
Young Innovations Authorizes 500M Share Repurchase Program
Wednesday, July 20, 2011 - 5:15pm | 178Young Innovations, Inc. (NASDAQ: YDNT) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable September 15, 2011 to all shareholders of record on August 15, 2011. The Board of Directors also authorized the repurchase of up to 500,000 shares of the...